102 related articles for article (PubMed ID: 19995227)
1. Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer.
Shih YC; Elting LS; Pavluck AL; Stewart A; Halpern MT
Cancer Invest; 2010 Jan; 28(1):46-53. PubMed ID: 19995227
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with immunotherapy use among newly diagnosed cancer patients.
Shih YC; Elting LS; Halpern MT
Med Care; 2009 Sep; 47(9):948-58. PubMed ID: 19704352
[TBL] [Abstract][Full Text] [Related]
3. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.
Yabroff KR; Mariotto AB; Feuer E; Brown ML
Health Econ; 2008 Aug; 17(8):947-59. PubMed ID: 17910108
[TBL] [Abstract][Full Text] [Related]
4. Cost determinants in aggressive non-Hodgkin's lymphoma.
van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA
Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's lymphoma in women with breast cancer.
Wiernik PH; Hu X; Ratech H; Fineberg S; Marino P; Schleider MA; Etkind P; Walewski JA
Cancer J; 2000; 6(5):336-42. PubMed ID: 11079174
[TBL] [Abstract][Full Text] [Related]
6. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
7. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
8. Cost of illness in patients with metastatic colorectal cancer.
Song X; Zhao Z; Barber B; Gregory C; Cao Z; Gao S
J Med Econ; 2011; 14(1):1-9. PubMed ID: 21108534
[TBL] [Abstract][Full Text] [Related]
9. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1209-1218. PubMed ID: 30796156
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy for metastatic colorectal cancer].
Iwasa S; Shimada Y
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for HIV-associated non-Hodgkin's lymphoma.
Newsom-Davis T; Ahamed E; Bower M
Expert Opin Biol Ther; 2009 Oct; 9(10):1313-24. PubMed ID: 19645631
[TBL] [Abstract][Full Text] [Related]
12. Economic analysis of psychosocial group therapy in women with metastatic breast cancer.
Lemieux J; Topp A; Chappell H; Ennis M; Goodwin PJ
Breast Cancer Res Treat; 2006 Nov; 100(2):183-90. PubMed ID: 16773438
[TBL] [Abstract][Full Text] [Related]
13. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
[TBL] [Abstract][Full Text] [Related]
14. Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin's lymphoma.
Cronin DP; Harlan LC; Clegg LX; Stevens JL; Yuan G; Davis TA
Hematol Oncol; 2005 Jun; 23(2):73-81. PubMed ID: 16170828
[TBL] [Abstract][Full Text] [Related]
15. A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
Fontelonga A; Kelly AJ; MacKintosh FR; Hall S; Monroe P; Wilson GS; Shaft D; Ruthven A; Ascensao JL
Bone Marrow Transplant; 1997 May; 19(10):983-8. PubMed ID: 9169642
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
17. The cost of treating relapsed indolent non-Hodgkin's lymphoma in an international setting: retrospective analysis of resource use.
Herold M; Sacchi S; Hieke K
Haematologica; 2002 Jul; 87(7):719-29; discussion 729. PubMed ID: 12091123
[TBL] [Abstract][Full Text] [Related]
18. [Hungarian experience with non-Hodgkin's lymphoma in childhood].
Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
Magy Onkol; 2006; 50(3):253-9. PubMed ID: 17099787
[TBL] [Abstract][Full Text] [Related]
19. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
Ramsey SD; Berry K; Etzioni R
Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
